Alvogen is the next generation pharmaceuticals company. Our business model ensures competitive advantage through focused in-house capabilities and a network of partners for enhanced speed and flexibility. Alvogen currently has commercial operations in 35 countries around the globe, with regional hubs in North America, Romania and Taiwan. 

Our passionate team is committed to continue to grow our business around the world and to becoming a top 10 global generic pharmaceuticals player. North America is our largest market with over 79 pending ANDA filings. Other markets include Romania, Hungary, Korea, Taiwan, Bulgaria, Japan, China and Russia.

Pipeline ANDA'S

Meet management


Alvogen’s leadership team is dedicated to fostering a dynamic change-driven culture committed to meeting the needs of our customers. Our organizational structure is lean and flexible, driving quick and effective decision making and thus enabling the company to bring new generic products quickly and safely to market.

Meet management

Lines of business

Alvogen's lines of business include: product development, contract manufacturing and research (CMO), and sales of generic medicines (Gx and Hx), biosimilars and OTC’s.

Alvogen's product  portfolio consists of a broad range of leading molecules for the treatment of conditions in the areas of oncology, cardiology, respiratory, neurology and gastroenterology in addition to a fast growing portfolio of biosimilars and OTC products.

Read more

Organizational culture

Life at Alvogen

Alvogen has offices around the world, from Bangalore to Bulgaria, but regardless of where we are, we nurture our values and a positive working environment by hiring street-smart, innovative, local people who share our spirit.

Join us

Vision 2020

A top 10 player

Our vision is to become the Preferred Partner by setting a new standard for the future of pharma. Five main pillars support our ambitious growth strategy and are the foundation for the Alvogen Star-Map, which serves as the framework for our focus areas and the actions that are needed to become a global leader.

Read more

Regional offices

Alvogen USA

With a fully integrated brand and generics business, the U.S. market is Alvogen’s single largest market. It is built on the strong foundation of Norwich Pharmaceutical Services, with a 130-year history and an unsurpassed regulatory track record.

Alvogen Central and Eastern Europe

Alvogen has built a solid platform for growth across the CEE region. With excellent manufacturing facilities in Romania and a packaging center in Serbia serving the entire region as a centralized supply chain.

Alvogen Asia

Alvogen is building a regional platform for growth across the APAC region, with commercial network in 11 countries. The company has manufacturing and R&D centers in Korea and Taiwan and hundreds of products on the market.



Alvogen has commercial operations in more than 30 countries, with regional hubs, manufacturing and R&D capabilities in the U.S., South Korea and Romania.

Alvogen has 350 generic products on the market, with over 200 strategically selected development projects in the pipeline. Connect with local teams to learn more about product offering in your region.

World offices